Ultragenyx’s LC-FAOD Odyssey Study: From Patient Experience to Patient Empowerment

June 02, 2021 • 01:00:16
Ultragenyx’s LC-FAOD Odyssey Study: From Patient Experience to Patient Empowerment
MitoAction Expert Series
Ultragenyx’s LC-FAOD Odyssey Study: From Patient Experience to Patient Empowerment

Jun 02 2021 | 01:00:16

/

Show Notes

Join MitoAction, Eliza Kruger and Kristin Voorhees from Ultragenyx Pharmaceutical on Friday, May 21, 2021 at 12:00pm EST for our monthly expert series presentation!

On this webinar, Ultragenyx representatives will discuss how insights and feedback from people living with LC-FAOD shaped the design of a new study: LC-FAOD Odyssey. This study uses digital technology developed by PicnicHealth to collate and organize medical records, allowing people living with LC-FAOD to contribute their anonymized data to advance research. Participants will learn about the study goals and how the community can participate, as well as see a demo of the technology and the opportunities it offers to patients and caregivers.

*This webinar is intended for U.S. members of the MitoAction community*

 

Other Episodes

Episode 0

October 21, 2020 • NaN
Episode Cover

Fatty Acid Oxidation Disorders - Dr. Jerry Vockley - 2/5/2016

What are fatty acid oxidation disorders, and why are they related to mitochondrial disorders? Additional areas of discussion include: Do patients with mitochondrial defects...

Listen

Episode

June 24, 2022 • 01:02:59
Episode Cover

Spectrum Needs, a New Comprehensive Nutritional Therapy for Autism, Functional Conditions and Mitochondrial Disease - 4/6/2018

Talking points include: -What does the medical literature say regarding the uses of nutritional therapies in the autism and related neurodevelopmental disorders? -What about...

Listen

Episode 0

February 14, 2021 • 00:44:59
Episode Cover

Patients as Partners in Drug Development - Dr. Madhu Davies - 2/12/21

Join MitoAction and Dr. Madhu Davies from Reneo Pharmaceuticals for our February Monthly Mito Expert Series titled “Patients as Partners in Drug Development.” About...

Listen